AAAAAA

   
Results: 1-11 |
Results: 11
Relationship of demographic and clinical factors to free and total prostate-specific antigen
Authors: Gelmann, EP Chia, D Pinsky, PF Andriole, GL Crawford, ED Reding, D Hayes, RB Kramer, BS Woodrum, DL Gohagan, JK Levin, DL
Citation: Ep. Gelmann et al., Relationship of demographic and clinical factors to free and total prostate-specific antigen, UROLOGY, 58(4), 2001, pp. 561-566
Antenatal corticosteroids revisited: Repeat courses - National Institutes of Health consensus development conference statement, August 17-18, 2000
Authors: Gilstrap, LC Hightower, ES Clewell, WH D'Alton, ME Damon, VG Escobedo, MB Frader, J Gjerdingen, DK Goddard-Finegold, J Goldenberg, RL Flowers, CE Hack, M Hansen, TN Kauffman, RE Dow, MM Keeler, EB Oh, W Hassenfeld, SK Reece, EA Roth, A Susman, EJ Shibley, JP Vogel, MG Banks, BA Esplin, MS French, N Guinn, D Jobe, AH Mercer, B Murphy, KE Padbury, JF Scott, JR Sinclair, JC Socol, M Wapner, RJ Ward, RM Alexander, D Bowersox, JA Elliott, JM Kramer, BS Spong, CY Whalen, JM Wright, L
Citation: Lc. Gilstrap et al., Antenatal corticosteroids revisited: Repeat courses - National Institutes of Health consensus development conference statement, August 17-18, 2000, OBSTET GYN, 98(1), 2001, pp. 144-150
Study design in the evaluation of breast cancer imaging technologies
Authors: Houn, F Bright, RA Bushar, HF Croft, BY Finder, CA Gohagan, JK Jennings, RJ Keegan, P Kessler, LG Kramer, BS Martynec, LO Robinowitz, M Sacks, WM Schultz, DG Wagner, RF
Citation: F. Houn et al., Study design in the evaluation of breast cancer imaging technologies, ACAD RADIOL, 7(9), 2000, pp. 684-692
Spiral computed tomography screening
Authors: Kramer, BS
Citation: Bs. Kramer, Spiral computed tomography screening, J MED SCREE, 7(3), 2000, pp. 121-122
Cancer screening
Authors: Kramer, BS Brawley, OW
Citation: Bs. Kramer et Ow. Brawley, Cancer screening, HEMAT ONCOL, 14(4), 2000, pp. 831
Understanding clinical trials - Preface
Authors: Allegra, CJ Kramer, BS
Citation: Cj. Allegra et Bs. Kramer, Understanding clinical trials - Preface, HEMAT ONCOL, 14(4), 2000, pp. XIII-XIV
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status
Authors: Gohagan, JK Prorok, PC Hayes, RB Kramer, BS
Citation: Jk. Gohagan et al., The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status, CONTR CL TR, 21(6), 2000, pp. 251S-272S
Early detection cancer research network
Authors: Srivastava, S Kramer, BS
Citation: S. Srivastava et Bs. Kramer, Early detection cancer research network, LAB INV, 80(8), 2000, pp. 1147-1148
Molecular genetic basis for early cancer detection and cancer susceptibility
Authors: Fong, KM Srivastava, S Gopal-Srivastava, R Kramer, BS
Citation: Km. Fong et al., Molecular genetic basis for early cancer detection and cancer susceptibility, MOLECULAR PATHOLOGY OF EARLY CANCER, 1999, pp. 13-26
Screening theory and study design: The basics
Authors: Prorok, PC Kramer, BS Gohagan, JK
Citation: Pc. Prorok et al., Screening theory and study design: The basics, BAS CLIN ON, 18, 1999, pp. 29-53
The role of prostate-specific antigen (PSA) testing patterns in the recentprostate cancer incidence decline in the United States
Authors: Legler, JM Feuer, EJ Potosky, AL Merrill, RM Kramer, BS
Citation: Jm. Legler et al., The role of prostate-specific antigen (PSA) testing patterns in the recentprostate cancer incidence decline in the United States, CANC CAUSE, 9(5), 1998, pp. 519-527
Risultati: 1-11 |